- Home
- FCBC vs ETON Comparison
FCBC vs ETON Comparison
Compare FCBC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCBC | ETON |
|---|---|---|
| Founded | 1874 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 612.1M | 498.8M |
| IPO Year | 1992 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FCBC | ETON |
|---|---|---|
| Price | $33.62 | $16.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $29.67 |
| AVG Volume (30 Days) | 49.8K | ★ 233.1K |
| Earning Date | 01-27-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.67% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.68 | N/A |
| Revenue | ★ $164,262,000.00 | $70,316,000.00 |
| Revenue This Year | $3.97 | $107.23 |
| Revenue Next Year | $9.85 | $29.72 |
| P/E Ratio | $12.61 | ★ N/A |
| Revenue Growth | 0.67 | ★ 102.77 |
| 52 Week Low | $31.21 | $11.09 |
| 52 Week High | $45.57 | $23.00 |
Technical Indicators
Market Signals| Indicator | FCBC | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 47.37 | 51.87 |
| Support Level | $33.35 | $16.27 |
| Resistance Level | $36.52 | $17.33 |
| Average True Range (ATR) | 0.92 | 0.64 |
| MACD | -0.14 | 0.15 |
| Stochastic Oscillator | 28.43 | 66.14 |
Price Performance
Historical ComparisonAbout FCBC First Community Bankshares Inc. (VA)
First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.